Physician profile
Randall Colvin
NPI 1124078118
$2,679.16
in general payments reported to CMS, 2019-2025
16 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $182 · 2021: $221 · 2022: $289 · 2023: $375 · 2024: $1,189 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,810.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Memed US, INC. | $716.62 | 2024 | Memed Bv Calibrator |
| Abbvie INC. | $505.52 | 2021-2024 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $443.93 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $395.92 | 2021-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $106.16 | 2019-2024 | Trelegy Ellipta |
| Boston Scientific Corporation | $84.79 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Astellas Pharma US INC | $76.80 | 2019-2024 | Veozah, Myrbetriq |
| Dexcom, INC. | $74.79 | 2021-2023 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $60.41 | 2019-2020 | |
| Pfizer INC. | $59.65 | 2021-2024 | |
| Allergan, INC. | $51.35 | 2020 | |
| Globus Medical, INC. | $33.89 | 2025 | Senza |
| Otsuka America Pharmaceutical, INC. | $22.17 | 2022 | |
| Cequr Corporation | $16.88 | 2023 | Cequr Simplicity |
| Supernus Pharmaceuticals, INC. | $15.21 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $15.07 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Colvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.